Press release
Biosimilars Market estimated close to $18 Bn between 2020 to 2025: Amgen, Roche, Sandoz, Dr. Reddy's, Teva
Biosimilars Market
BRUSSELS, BELGIUM, February XX, 2022/XX (Link)/ -- A biosimilar is a biological product that is similar to a reference biologic with no clinically meaningful differences in terms of potency, purity, and safety.
Worldwide Biosimilars Market is estimated close to $18 Bn (2020) growing at a double-digit rate.
Loss of patent safety for originator brands to drive the biosimilar market growth
A key driver of biosimilar market growth over the next 5-10 years is the number of losses of protection (LoP) events for originator brands. In the US alone, 66 biologic U.S. patents are expiring between 2020 and 2025, owing to which the biosimilar market is on the cusp of a significant boost. Oncology is one of the major therapeutic areas in biosimilars market and by 2023, patents on nearly 20 oncology biologics will expire, which could lead to more biosimilars to enter in oncology space and propelling oncology biosimilars market.
Steady growth in biosimilar approvals in the US market
The US biosimilars market is growing across multiple therapeutic areas. From 1 approval in 2015, the number of FDA approvals have increased to 10 in 2019 (only 3 approvals in 2020 impacted by COVID as shown in figure below).
The stable and consistent increase in number of biosimilar approvals and market availability in US is driving the growth in the US biosimilars market. In 2015, only 1 biosimilar product was available for use in market and this number reached to 19 by end of 2020.
"There is a huge potential for biosimilar market growth as they deliver significant benefits to the healthcare community. Biosimilars help augment overall treatment options, positively impact patients suffering from life-threatening conditions, whilst contributing to the quality and financial sustainability of healthcare systems." - CEO, Leading Biosimilars Company
Geographic Snapshot: Biosimilars Market
Europe is the leading market for biosimilars owing to adoption of more liberal policies which has enabled greater market access. On the other hand, US has taken a more protective approach towards originator brands, further influenced by lobbying from pharma companies.
Owing to this, the biosimilar adoption is relatively slower in US. However, the US biosimilar landscape is now evolving rapidly. There were 29 biosimilars approved in US compared to 11 in EU in the initial six years. Also, in April 2021, the US signed two bipartisan bills to reduce prescription drug prices by supporting generics/biosimilars. Such developments will fuel the US market growth.
The key players in the global biosimilars market include Amgen, Roche, Sandoz, Dr. Reddy's, Teva, Pfizer, Eli Lilly, Samsung, Biocon, Boehringer, and Mylan.
Get Customized Report on Biosimilars Market @ https://meditechinsights.com/global-biosimilars-market/
Contact Us:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Medi-Tech Insights is a healthcare-focused business research & insights firm. We have successfully completed 100+ projects in Healthcare IT, MedTech, Medical Devices & Pharma Services in the areas of due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry leading CXO, VPs and key demand/supply side decision-makers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilars Market estimated close to $18 Bn between 2020 to 2025: Amgen, Roche, Sandoz, Dr. Reddy's, Teva here
News-ID: 2697971 • Views: …
More Releases from Meditech insights
Sepsis Diagnostics Market: Comprehensive study explores Healthy Growth in near F …
Sepsis is a life-threatening medical emergency. It is body's reaction to infection that may lead to a systemic inflammatory reaction, tissue damage, and ultimately organ dysfunction and/or failure.
As per WHO, globally, sepsis affects around 49 million people each year. Early diagnosis of sepsis is critical for patient outcomes. However, diagnosing sepsis is not an easy task as there is no particular symptom or sign that are directly related to the…
Surgical Instrument Tracking Systems Market expected to reach US$ 400 Million by …
Surgical instrument tracking systems is a mixture of latest scanning technology and application software for inventory management. It provides a solution which allows users to maintain Quality, Compliance and Traceability of Instruments in work place. Starting in 2014, different classes of medical devices are included in UDI program to provide more accurate tracking of medical devices. Moreover, EU acted to adopt UDI in 2017, under the EU MDR.
Worldwide Surgical Instrument…
Medical Lasers Market To Boost Business Scope With Key Players - Lumenis, Dentsp …
Medical lasers use precisely focused light sources to treat or remove tissues. These are used during cosmetic surgeries, refractive eye surgeries, dental procedures, and general surgeries. Further, medical lasers are also used in radiotherapy for patient positioning.
Global Medical Lasers Market is estimated close to $3.5 billion (2020). Market segments are growing at a CAGR from 8-12% through 2020-2025. The Medical Lasers Market development is driven by growing medical/aesthetic procedures,…
Allergy Diagnostics Market is Thriving Worldwide | key players Such as Siemens H …
Growing cases of allergic diseases (asthma, allergic rhinitis, atopic dermatitis, and food allergy), rising environmental pollution levels, high volume consumption of processed food and beverages, advent of mHealth in allergy diagnosis & care and growing awareness about allergic diseases are some of the key factors driving the Global Allergy Diagnostics Market.
The prevalence of allergic diseases globally has continued to grow in the industrialized world for more than 50 years. Mobile…
More Releases for Biosimilars
Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes…
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Biosimilars Market Size During the Forecast Period?
The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,…
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth?
The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
